Important precautions and safety guidance during use of odexibat (Belvi)

1. Overview of Drugs

Odevixibat (trade name: Bei Erwei) is a new oral small molecule drug, mainly used to treat children and adults with progressive cholestatic liver disease, especially patients with hereditary cholestasis diseases (such as PFIC, progressive familial intrahepatic cholestasis). The drug reduces bile acid reabsorption from the intestine by selectively inhibiting intestinal bile acid transporter (IBAT, ileal bile acid transporter), thereby reducing bile acid levels in the blood, alleviating itching symptoms and improving liver damage indicators.

The advantage of Odevixibat lies in its non-systemic effects, which are mainly limited to the intestinal tract, thereby reducing systemic toxic effects. This drug is an oral dosage form, which is convenient for long-term management. However, in order to ensure efficacy and safety, it is necessary to strictly follow medical instructions and pay attention to relevant monitoring indicators during use.

2. Precautions before taking medication

1.Liver function assessment

Before starting to use odexibat, patients need to undergo basic assessments such as liver function, serum bile acids, and blood routine. Patients with severe liver function abnormalities or decompensated liver disease should use it under the guidance of a professional doctor and have regular follow-up visits.

2.Combined disease and drug history

Patients should truthfully inform their doctors of all co-morbidities and medications they are taking before taking medication, especially those that may affect bile acid metabolism, such as choleretics, fat-soluble vitamin supplements and other liver drugs. Avoid drug-drug interactions that may affect efficacy or increase the risk of adverse reactions.

3.Age and weight restrictions

Odevixibat’s clinical studies are mainly focused on pediatric patients, and data on adult use are relatively limited. Pediatric patients should choose an appropriate dose based on weight and age, follow the doctor's dosage adjustment recommendations, and avoid overdosing or underdosing.

3. Important precautions during medication

1.Dosage and administration method

Odesibat is usually taken orally once a day or in divided doses as directed by your doctor, with or without food. Patients should fix the medication time and avoid increasing or decreasing the dose on their own or stopping the medication at will to ensure stable blood concentration.

2.Monitor blood and liver function indicators

Serum bile acids and liver function indicators need to be reviewed regularly during treatment (ALT, AST, total bilirubin), blood routine and fat-soluble vitamin levels. If abnormal increases in bile acids or liver function indicators are found, the doctor may adjust the dose or suspend the medication.

3.Focus on nutrition and vitamin absorption

Since odexibat works by inhibiting bile acid reabsorption, long-term medication may affect the absorption of fat-soluble vitamins (A, D, E, K). Patients should take vitamin supplements or blood monitoring as recommended by their doctor to prevent bone, vision or blood coagulation abnormalities caused by vitamin deficiency.

4.Common adverse reactions and responses

Patients may experience symptoms such as mild diarrhea, bloating, abdominal pain, or loss of appetite while taking the medication. Generally, these symptoms are mild and tolerable, and it is recommended to alleviate them by adjusting diet, replenishing water, or taking medication in batches. If symptoms are severe or persistent, you should contact your doctor promptly for treatment.

4. Special groups and safety guidance

1.Pregnant and lactating women

Odesibat lacks adequate safety data in pregnant and lactating women and should be used with caution or avoided. If you have an unexpected pregnancy during use, you should inform your doctor immediately and assess the risks of taking the medication.

2.Long-term management of pediatric patients

Pediatric patients need to regularly follow up on their weight, height and growth and development while taking the medicine, and pay attention to possible nutrient absorption problems. Parents should guide their children to take medicine on time, record changes in symptoms, and maintain communication with their doctors.

3. Adjustments to daily routine and lifestyle

Patients should maintain a regular schedule, eat a reasonable diet, and avoid overeating and high-fat diets to reduce gastrointestinal discomfort and assist the medication to achieve optimal efficacy. Regular physical examinations and laboratory examinations are important to ensure long-term safe use.

5. Summary

Odevixibat (Odevixibat), as a new oral drug for the treatment of cholestatic liver disease, can effectively improve itching symptoms and liver damage by inhibiting intestinal bile acid reabsorption. However, during use, patients need to strictly follow the doctor's instructions and take medication, pay attention to liver function and bile acid levels, regularly monitor fat-soluble vitamins and nutritional status, and pay attention to common adverse reactions. Special groups such as children, pregnant women and patients with severe liver function abnormalities need to take medication under the guidance of a professional doctor. Through standardized use and scientific management, odexibat can maximize its therapeutic effect while ensuring safety, providing patients with a long-term solution to improve their quality of life.

Reference link:https://www.drugs.com